Table 1.
Mutations in KCa channels that are associated in human diseases, their location in the channel protein, functional implications and related references.
Gene/protein | Disease phenotype | Mutation/location in the protein | Functional effects | Reference |
---|---|---|---|---|
∗KCNN3/SK3 | Idiopathic non-cirrhotic portal hypertension | V450L/intracellular loop between the S4 and S5 transmembrane segments | De novo mutation | Koot et al., 2016 |
Functional effects currently unknown. | ||||
KCNN3/SK3 | Schizophrenia | hSK3Δ (L283fs287X mutation)/N-terminal cytoplasmic region (deletion) | Suppresses SK currents Disrupts SK-NMDAR coupling | Miller et al., 2001; Soden et al., 2013 |
∗KCNMB1/BKβ1 | Diastolic hypertension | E65K/Extracellular loop connecting β1 two transmembrane segments. | Gain-of-function mutation rendering enhanced Ca2+ sensitivity | Fernandez-Fernandez et al., 2004 |
KCNMA1/BKα | Generalized epilepsy and paroxysmal dyskinesia | D434G/RCK1 domain | Gain-of-function mutation leading to enhanced Ca2+ sensitivity | Du et al., 2005; Yang J. et al., 2010 |
KCNMA1/BKα | Epilepsy | N995S/RCK2 domain | De novo mutation Shifts the voltage dependence to more negative potentials without altering Ca2+ sensitivity | Li et al., 2018 |
KCNMB3/BKβ3 | Idiopathic generalized epilepsy | Del A750/C-terminal region (truncation of 21 amino acids) | BK inactivation | Hu et al., 2003; Lorenz et al., 2007 |
This table includes other mutations not linked to neurological diseases that are not discussed in detail in the main text (indicated with asterisks).